No Data
No Data
No Data
No Data
No Data
Buy Rating Reaffirmed for Syndax Pharmaceuticals on Strong Drug Pipeline and Strategic Partnerships
TipRanksApr 26 06:15 ET
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum
Syndax Pharmaceuticals (NASDAQ:SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will participate in a fireside chat at the at Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024, at 11:00 a.m. ET.
PRNewswireApr 10 16:05 ET
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Inozyme Pharma (INZY) and PTC Therapeutics (PTCT)
TipRanksApr 9 05:40 ET
Analysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Legend Biotech (LEGN)
TipRanksApr 8 19:50 ET
Buy Rating Affirmed for Syndax Pharmaceuticals Amidst Strong Clinical Results and Strategic Growth Prospects
TipRanksApr 8 11:35 ET
Express News | Live On CNBC, StemPoint Capital CIO Michelle Ross Mentioned Syndax Pharmaceuticals, Shares Spiked Higher
Moomoo 24/7Apr 3 12:52 ET
No Data
No Data